DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,145,685 | -86.5% | 24,771 | -85.5% | 0.04% | -82.6% |
Q4 2022 | $45,492,988 | +28.8% | 171,400 | +25.3% | 0.21% | +2.4% |
Q3 2022 | $35,334,000 | +264.8% | 136,800 | +314.3% | 0.21% | +76.3% |
Q1 2022 | $9,685,000 | +469.0% | 33,016 | +420.7% | 0.12% | +1211.1% |
Q2 2021 | $1,702,000 | -90.3% | 6,341 | -94.5% | 0.01% | -93.4% |
Q4 2019 | $17,634,000 | +5.9% | 114,900 | -0.3% | 0.14% | +9.7% |
Q3 2019 | $16,653,000 | -28.3% | 115,300 | -29.0% | 0.12% | -45.9% |
Q2 2019 | $23,222,000 | +197.7% | 162,500 | +114.8% | 0.23% | +65.9% |
Q4 2018 | $7,800,000 | +212.8% | 75,638 | +229.7% | 0.14% | +475.0% |
Q3 2018 | $2,494,000 | -49.5% | 22,940 | -54.2% | 0.02% | -40.0% |
Q2 2018 | $4,937,000 | -88.3% | 50,035 | -89.0% | 0.04% | -81.4% |
Q4 2017 | $42,327,000 | +97.4% | 456,011 | +82.4% | 0.22% | +126.3% |
Q3 2017 | $21,445,000 | +1.6% | 250,000 | 0.0% | 0.10% | -17.4% |
Q2 2017 | $21,098,000 | -1.3% | 250,000 | 0.0% | 0.12% | -28.1% |
Q1 2017 | $21,383,000 | +397.2% | 250,000 | +487.1% | 0.16% | +138.8% |
Q2 2016 | $4,301,000 | -96.0% | 42,584 | -96.6% | 0.07% | -93.2% |
Q2 2015 | $106,988,000 | +27054.3% | 1,250,000 | +27073.9% | 0.99% | +10855.6% |
Q4 2014 | $394,000 | +32.7% | 4,600 | +17.9% | 0.01% | +50.0% |
Q3 2014 | $297,000 | -23.1% | 3,900 | -20.4% | 0.01% | -25.0% |
Q2 2014 | $386,000 | – | 4,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |